Evidence map›Paper›PMID 35442725›Full record

ArticleScience advances2022

Epac1 activation by cAMP regulates cellular SUMOylation and promotes the formation of biomolecular condensates.

Wenli Yang, William G Robichaux, Fang C Mei, Wei Lin, Li Li, Sheng Pan, Mark A White, Yuan Chen, Xiaodong Cheng

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Protein SUMOylation promotes cAMP-independent EPAC1 activation.Cellular and molecular life sciences : CMLS · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wenli YangDepartment of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, TX, USA.ORCID 0000-0002-4484-2280
William G RobichauxDepartment of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, TX, USA.
Fang C MeiDepartment of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, TX, USA.ORCID 0000-0002-2589-1036
Wei LinDepartment of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, TX, USA.
Li LiBrown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA.ORCID 0000-0002-1313-3916
Sheng PanBrown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA.
Mark A WhiteSealy Center for Structural Biology and Molecular Biophysics, The University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0003-1057-4203
Yuan ChenDepartment of Surgery and Moores Cancer Center, UC San Diego Health, La Jolla, CA, USA.
Xiaodong ChengDepartment of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, TX, USA.ORCID 0000-0002-3479-1694
Brown Foundation · USThe University of Texas Medical Branch at Galveston · USUC San Diego Health System · US

Funding

Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple MyelomaR01CA212119 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, YUAN · 2017 to 2021
$2.8M
SUMO Modification and Cancer TherapyR01CA265410 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, YUAN · 2021 to 2025
$2.5M
K-Ras sumoylation in cell proliferation and transformationR01CA216987 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHEN, YUAN, DAI, WEI · 2017 to 2021
$2.5M
Exchange Protein directly Activated by cAMP (EPAC): Structure, Function and TherapeuticsR35GM122536 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHENG, XIAODONG · 2017 to 2021
$1.9M
NCI NIH HHS R01 CA212119NCI NIH HHS R01 CA216987NCI NIH HHS R01 CA265410NIGMS NIH HHS R35 GM122536
6 · The paper itself

Abstract

Protein SUMOylation plays an essential role in maintaining cellular homeostasis when cells are under stress. However, precisely how SUMOylation is regulated, and a molecular mechanism linking cellular stress to SUMOylation, remains elusive. Here, we report that cAMP, a major stress-response second messenger, acts through Epac1 as a regulator of cellular SUMOylation. The Epac1-associated proteome is highly enriched with components of the SUMOylation pathway. Activation of Epac1 by intracellular cAMP triggers phase separation and the formation of nuclear condensates containing Epac1 and general components of the SUMOylation machinery to promote cellular SUMOylation. Furthermore, genetic knockout of Epac1 obliterates oxidized low-density lipoprotein-induced cellular SUMOylation in macrophages, leading to suppression of foam cell formation. These results provide a direct nexus connecting two major cellular stress responses to define a molecular mechanism in which cAMP regulates the dynamics of cellular condensates to modulate protein SUMOylation.

Indexed as

Cyclic AMPGuanine Nucleotide Exchange FactorsBiomolecular CondensatesFoam CellsSumoylationCyclic AMPGuanine Nucleotide Exchange Factors

Identifiers

PMID35442725
PMCPMC9020664
OpenAlexW4224222578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.